1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Introduction
2.2. Define: Research Objective
2.3. Determine: Research Design
2.4. Prepare: Research Instrument
2.5. Collect: Data Source
2.6. Analyze: Data Interpretation
2.7. Formulate: Data Verification
2.8. Publish: Research Report
2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19

6. Sirolimus Market, by Application
6.1. Introduction
6.2. Catheter Devices
6.3. Lymphangioleiomyomatosis(LAM)
6.4. Organ Transplant Rejection
6.5. Sirolimus Coated Balloons

7. Sirolimus Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Pharmacies
7.4. Retail Pharmacies

8. California Sirolimus Market

9. Florida Sirolimus Market

10. Illinois Sirolimus Market

11. New York Sirolimus Market

12. Ohio Sirolimus Market

13. Pennsylvania Sirolimus Market

14. Texas Sirolimus Market

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Aadi Bioscience, Inc.
16.2. Alkermes plc
16.3. Aurisco Pharmaceutical Co., Ltd.
16.4. Beijing THTD Pharmaceutical Technology Co., Ltd.
16.5. Cadila Healthcare Ltd
16.6. Chongqing Daxin Pharmaceutical Co., Ltd.
16.7. Chunghwa Chemical Synthesis & Biotech Co. Ltd.
16.8. Concept Medical, Inc.
16.9. Concord Biotech Limited
16.10. Cordis Corporation
16.11. Euticals Inc.
16.12. Fujian Kerui Pharmaceutical Co., Ltd.
16.13. Glenmark Pharmaceuticals Limited
16.14. Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd.
16.15. Intas Pharmaceuticals Ltd
16.16. M.A. Med Alliance SA
16.17. Pfizer Inc.
16.18. Sandoz International GmbH
16.19. Shandong Octagon Chemicals Limited
16.20. Stentys
16.21. Tiefenbacher API + Ingredients GmbH & Co. KG
16.22. TIEFENBACHER GROUP
16.23. Torrent Pharmaceuticals Ltd.
16.24. Zhejiang Hisun Pharmaceutical Co. Ltd

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES SIROLIMUS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES SIROLIMUS MARKET: MARKET DYNAMICS
FIGURE 3. UNITED STATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 4. UNITED STATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2027
FIGURE 6. UNITED STATES SIROLIMUS MARKET SIZE, BY CATHETER DEVICES, 2018-2027 (USD MILLION)
FIGURE 7. UNITED STATES SIROLIMUS MARKET SIZE, BY CATHETER DEVICES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 8. UNITED STATES SIROLIMUS MARKET SIZE, BY LYMPHANGIOLEIOMYOMATOSIS(LAM), 2018-2027 (USD MILLION)
FIGURE 9. UNITED STATES SIROLIMUS MARKET SIZE, BY LYMPHANGIOLEIOMYOMATOSIS(LAM), BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES SIROLIMUS MARKET SIZE, BY ORGAN TRANSPLANT REJECTION, 2018-2027 (USD MILLION)
FIGURE 11. UNITED STATES SIROLIMUS MARKET SIZE, BY ORGAN TRANSPLANT REJECTION, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 12. UNITED STATES SIROLIMUS MARKET SIZE, BY SIROLIMUS COATED BALLOONS, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES SIROLIMUS MARKET SIZE, BY SIROLIMUS COATED BALLOONS, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 14. UNITED STATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
FIGURE 15. UNITED STATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2020 VS 2027 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 17. UNITED STATES SIROLIMUS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 18. UNITED STATES SIROLIMUS MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES SIROLIMUS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES SIROLIMUS MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES SIROLIMUS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES SIROLIMUS MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2020 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES SIROLIMUS MARKET: FPNV POSITIONING MATRIX
FIGURE 24. UNITED STATES SIROLIMUS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 25. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES SIROLIMUS MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES SIROLIMUS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES SIROLIMUS MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES SIROLIMUS MARKET SIZE, BY CATHETER DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES SIROLIMUS MARKET SIZE, BY LYMPHANGIOLEIOMYOMATOSIS(LAM), BY STATE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES SIROLIMUS MARKET SIZE, BY ORGAN TRANSPLANT REJECTION, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES SIROLIMUS MARKET SIZE, BY SIROLIMUS COATED BALLOONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES SIROLIMUS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES SIROLIMUS MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES SIROLIMUS MARKET SIZE, BY ONLINE PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES SIROLIMUS MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES SIROLIMUS MARKET: SCORES
TABLE 13. UNITED STATES SIROLIMUS MARKET: BUSINESS STRATEGY
TABLE 14. UNITED STATES SIROLIMUS MARKET: PRODUCT SATISFACTION
TABLE 15. UNITED STATES SIROLIMUS MARKET: RANKING
TABLE 16. UNITED STATES SIROLIMUS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 17. UNITED STATES SIROLIMUS MARKET: MERGER & ACQUISITION
TABLE 18. UNITED STATES SIROLIMUS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 19. UNITED STATES SIROLIMUS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 20. UNITED STATES SIROLIMUS MARKET: INVESTMENT & FUNDING
TABLE 21. UNITED STATES SIROLIMUS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 22. UNITED STATES SIROLIMUS MARKET: LICENSE & PRICING

Companies Mentioned

Aadi Bioscience, Inc.
Alkermes plc
Aurisco Pharmaceutical Co., Ltd.
Beijing THTD Pharmaceutical Technology Co., Ltd.
Cadila Healthcare Ltd
Chongqing Daxin Pharmaceutical Co., Ltd.
Chunghwa Chemical Synthesis & Biotech Co. Ltd.
Concept Medical, Inc.
Concord Biotech Limited
Cordis Corporation
Euticals Inc.
Fujian Kerui Pharmaceutical Co., Ltd.
Glenmark Pharmaceuticals Limited
Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd.
Intas Pharmaceuticals Ltd
M.A. Med Alliance SA
Pfizer Inc.
Sandoz International GmbH
Shandong Octagon Chemicals Limited
Stentys
Tiefenbacher API + Ingredients GmbH & Co. KG
TIEFENBACHER GROUP
Torrent Pharmaceuticals Ltd.
Zhejiang Hisun Pharmaceutical Co. Ltd